Naka; Tetsuji

Patent Applications and Registrations

Patent applications and USPTO patent grants for Naka; Tetsuji.The latest application filed is for "leucine-rich alpha2 glycoprotein composition".

Company Profile

4.6.11

Naka; Tetsuji - Ibaraki JP
NAKA; Tetsuji - Ibaraki-shi JP
Naka; Tetsuji - Osaka JP
Naka; Tetsuji - Kochi-shi Kochi
Naka; Tetsuji - Shinjuku-ku Tokyo
Naka; Tetsuji - Toyonaka JP
Naka; Tetsuji - Suita JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-glypican-1-immunizing antigen receptor Grant 11,370,845 - Yaguchi , et al. June 28, 2	2022-06-28
Leucine-rich Alpha2 Glycoprotein Composition App 20220127314 - TAKAYAMA; Shigeo ; et al.	2022-04-28
Immunoassay And Measurement Reagent For Leucine-rich Alpha2 Glycoprotein App 20210382041 - TAKAYAMA; Shigeo ; et al.	2021-12-09
Esophageal Cancer Marker And Use Thereof App 20210340275 - Naka; Tetsuji ; et al.	2021-11-04
Anti-gpc-1 Antibody App 20200308299 - Naka; Tetsuji ; et al.	2020-10-01
Therapeutic Drug For Malignant Tumors App 20190023781 - Naka; Tetsuji ; et al.	2019-01-24
Therapeutic drug for malignant tumors Grant 10,174,111 - Naka , et al. J	2019-01-08
Esophageal Cancer Marker And Use Thereof App 20180362658 - Naka; Tetsuji ; et al.	2018-12-20
Esophageal cancer marker and use thereof Grant 10,077,316 - Naka , et al. September 18, 2	2018-09-18
Anti-glypican-1-immunizing Antigen Receptor App 20180230230 - Yaguchi; Tomonori ; et al.	2018-08-16
Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory disease Grant 9,611,475 - Naka , et al. April 4, 2	2017-04-04
Esophageal Cancer Marker And Use Thereof App 20170066836 - NAKA; Tetsuji ; et al.	2017-03-09
Therapeutic Drug For Malignant Tumors App 20170051056 - NAKA; Tetsuji ; et al.	2017-02-23
Prophylactic And/or Therapeutic Agent For Inflammatory Disease, And Method For Screening Prophylactic And/or Therapeutic Drug For Inflammatory Disease App 20160083725 - Naka; Tetsuji ; et al.	2016-03-24
Screening method for a substance having hypoglycemic activity by using STAT-induced inhibitor of STAT function-1 Grant 7,247,424 - Kishimoto , et al. July 24, 2	2007-07-24
Method of screening hypoglycemic substance by using stat inhibitory factor-1 App 20030186215 - Kishimoto, Tadamitsu ; et al.	2003-10-02
STAT function-regulatory protein Grant 6,514,725 - Kishimoto , et al. February 4, 2	2003-02-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.